{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:05:09Z","timestamp":1792289109894,"version":"4.4.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>Systemic pilocarpine administration has been widely implemented to generate rodent models of mesial temporal lobe epilepsy (mTLE), but pilocarpine-induced status epilepticus (SE) in mice causes a high mortality rate, likely due to cardiorespiratory collapse associated with prolonged seizures. Although it has been well known that SE impairs the functional properties of GABARs and benzodiazepine is not effective in treating late SE both in humans and experimental animals, diazepam is still the most commonly used medication to abort SE in pilocarpine-mTLE models. Here, we instead used levetiracetam (LEV), a specific synaptic vesicle protein 2 (SV2) inhibitor in presynaptic terminals, to abort SE and achieved a substantially increased survival rate, providing a robust experimental paradigm to improve animal welfare, research cost, and experimental design. Comparable to previous studies, these mice developed reliable seizures and pathological changes in the hippocampus, including neuronal loss, gliosis, and mossy fiber sprouting. In summary, our optimized LEV-treated, pilocarpine-based protocol establishes a reliable mouse model of mTLE with significantly improved survival outcomes.<\/jats:p>","DOI":"10.3389\/fnins.2025.1592014","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T07:46:09Z","timestamp":1746171969000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Refinement of the pilocarpine-induced status epilepticus model in mice to improve mortality outcomes"],"prefix":"10.3389","volume":"19","author":[{"given":"Mi","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41593-022-01044-2","article-title":"Altered adult neurogenesis and gliogenesis in patients with mesial temporal lobe epilepsy","volume":"25","author":"Ammothumkandy","year":"2022","journal-title":"Nat. Neurosci."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41467-017-02577-y","article-title":"Multi-day rhythms modulate seizure risk in epilepsy","volume":"9","author":"Baud","year":"2018","journal-title":"Nat. Commun."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S1474-4422(15)00042-3","article-title":"Status epilepticus in adults","volume":"14","author":"Betjemann","year":"2015","journal-title":"Lancet Neurol."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0920-1211(00)00175-3","article-title":"Ketamine controls prolonged status epilepticus","volume":"42","author":"Borris","year":"2000","journal-title":"Epilepsy Res."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1002\/cne.24226","article-title":"Seizure frequency correlates with loss of dentate gyrus GABAergic neurons in a mouse model of temporal lobe epilepsy","volume":"525","author":"Buckmaster","year":"2017","journal-title":"J. Comp. Neurol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/j.1528-1157.1991.tb05533.x","article-title":"Long-term effects of pilocarpine in rats: structural damage of the brain triggers kindling and spontaneous recurrent seizures","volume":"32","author":"Cavalheiro","year":"1991","journal-title":"Epilepsia"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/S0140-6736(20)30611-5","article-title":"Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial","volume":"395","author":"Chamberlain","year":"2020","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3390\/ph15040475","article-title":"Levetiracetam mechanisms of action: from molecules to systems","volume":"15","author":"Contreras-Garcia","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0006-8993(88)90681-6","article-title":"Chronic seizures and collateral sprouting of dentate mossy fibers after kainic acid treatment in rats","volume":"474","author":"Cronin","year":"1988","journal-title":"Brain Res."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1111\/epi.17377","article-title":"Dorsal bed nucleus of stria terminalis in depressed and nondepressed temporal lobe epilepsy patients","volume":"63","author":"Dhaher","year":"2022","journal-title":"Epilepsia"},{"key":"ref11","volume-title":"GABA Receptor Positive Allosteric Modulators","author":"Edwards","year":"2025"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1046\/j.1528-1157.43.s.5.41.x","article-title":"Behavioral, morphologic, and electroencephalographic evaluation of seizures induced by intrahippocampal microinjection of pilocarpine","volume":"43","author":"Furtado Mde","year":"2002","journal-title":"Epilepsia"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.expneurol.2007.06.021","article-title":"Behavioral alterations in the pilocarpine model of temporal lobe epilepsy in mice","volume":"207","author":"Groticke","year":"2007","journal-title":"Exp. Neurol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.yebeh.2003.12.004","article-title":"Levetiracetam prevents changes in levels of brain-derived neurotrophic factor and neuropeptide Y mRNA and of Y1-and Y5-like receptors in the hippocampus of rats undergoing amygdala kindling: implications for antiepileptogenic and mood-stabilizing properties","volume":"5","author":"Husum","year":"2004","journal-title":"Epilepsy Behav."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1111\/epi.16868","article-title":"Defining the latent period of epileptogenesis and epileptogenic zone in a focal cortical dysplasia type II (FCDII) rat model","volume":"62","author":"Kao","year":"2021","journal-title":"Epilepsia"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/ana.26773","article-title":"Sudden unexpected death in epilepsy and respiratory defects in a mouse model of DEPDC5-related epilepsy","volume":"94","author":"Kao","year":"2023","journal-title":"Ann. Neurol."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s40263-022-00940-2","article-title":"Benzodiazepines in the Management of Seizures and Status Epilepticus: a review of routes of delivery, pharmacokinetics, efficacy, and tolerability","volume":"36","author":"Kienitz","year":"2022","journal-title":"CNS Drugs"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1111\/epi.17211","article-title":"Loss of hippocampal dentation in hippocampal sclerosis and its relationship to memory dysfunction","volume":"63","author":"Kilpattu Ramaniharan","year":"2022","journal-title":"Epilepsia"},{"key":"ref19","volume-title":"Levetiracetam","author":"Kumar","year":"2025"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1016\/S0140-6736(19)30724-X","article-title":"Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial","volume":"393","author":"Lyttle","year":"2019","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.expneurol.2012.08.022","article-title":"Rapid epileptogenesis in the mouse pilocarpine model: video-EEG, pharmacokinetic and histopathological characterization","volume":"238","author":"Mazzuferi","year":"2012","journal-title":"Exp. Neurol."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/j.1528-1157.1993.tb02123.x","article-title":"Circuit mechanisms of seizures in the pilocarpine model of chronic epilepsy: cell loss and mossy fiber sprouting","volume":"34","author":"Mello","year":"1993","journal-title":"Epilepsia"},{"key":"ref23","first-page":"51\u20139; discussion 9\u201360","article-title":"Granule cell dispersion in relation to mossy fiber sprouting, hippocampal cell loss, silent period and seizure frequency in the pilocarpine model of epilepsy","volume":"9","author":"Mello","year":"1992","journal-title":"Epilepsy Res. Suppl."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/anae.15606","article-title":"Management of status epilepticus: a narrative review","volume":"77","author":"Migdady","year":"2022","journal-title":"Anaesthesia"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ejphar.2009.07.020","article-title":"Pilocarpine vs. lithium-pilocarpine for induction of status epilepticus in mice: development of spontaneous seizures, behavioral alterations and neuronal damage","volume":"619","author":"Muller","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"107728","DOI":"10.1016\/j.neuropharm.2019.107728","article-title":"Changes in excitatory and inhibitory receptor expression and network activity during induction and establishment of epilepsy in the rat reduced intensity status epilepticus (RISE) model","volume":"158","author":"Needs","year":"2019","journal-title":"Neuropharmacology"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1001\/jamaneurol.2019.1268","article-title":"Change in mortality of generalized convulsive status epilepticus in high-income countries over time: a systematic review and Meta-analysis","volume":"76","author":"Neligan","year":"2019","journal-title":"JAMA Neurol."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/nyas.13147","article-title":"Benzodiazepine-refractory status epilepticus: pathophysiology and principles of treatment","volume":"1378","author":"Niquet","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.neulet.2005.05.048","article-title":"Evaluation of levetiracetam effects on pilocarpine-induced seizures: cholinergic muscarinic system involvement","volume":"385","author":"Oliveira","year":"2005","journal-title":"Neurosci. Lett."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.celrep.2014.06.032","article-title":"Contribution of aberrant GluK2-containing kainate receptors to chronic seizures in temporal lobe epilepsy","volume":"8","author":"Peret","year":"2014","journal-title":"Cell Rep."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","article-title":"Modification of seizure activity by electrical stimulation. II. Motor seizure","volume":"32","author":"Racine","year":"1972","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"ref32","volume-title":"The principles of humane experimental technique","author":"Russell WMSaB","year":"1959"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1474-4422(02)00163-1","article-title":"When should temporal-lobe epilepsy be treated surgically?","volume":"1","author":"Spencer","year":"2002","journal-title":"Lancet Neurol."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1111\/epi.13837","article-title":"Costs, length of stay, and mortality of super-refractory status epilepticus: a population-based study from Germany","volume":"58","author":"Strzelczyk","year":"2017","journal-title":"Epilepsia"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1535-7597.2002.00032.x","article-title":"Seizure-induced axonal sprouting: assessing connections between injury, local circuits, and Epileptogenesis","volume":"2","author":"Sutula","year":"2002","journal-title":"Epilepsy Curr."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0006-8993(84)90177-X","article-title":"Seizures produced by pilocarpine in mice: a behavioral, electroencephalographic and morphological analysis","volume":"321","author":"Turski","year":"1984","journal-title":"Brain Res."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"105547","DOI":"10.1016\/j.nbd.2021.105547","article-title":"Substantial outcome improvement using a refined pilocarpine mouse model of temporal lobe epilepsy","volume":"161","author":"Vigier","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1016\/j.neuron.2022.07.020","article-title":"Enhanced excitability of the hippocampal CA2 region and its contribution to seizure activity in a mouse model of temporal lobe epilepsy","volume":"110","author":"Whitebirch","year":"2022","journal-title":"Neuron"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"e25393","DOI":"10.1002\/jnr.25393","article-title":"Efficacy of low-dose ketamine and Propofol in the treatment of experimental refractory status epilepticus on male rats","volume":"102","author":"Yilmaz","year":"2024","journal-title":"J. Neurosci. Res."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.neuropharm.2009.12.007","article-title":"Intravenous levetiracetam in the rat pilocarpine-induced status epilepticus model: behavioral, physiological and histological studies","volume":"58","author":"Zheng","year":"2010","journal-title":"Neuropharmacology"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2025.1592014\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T07:46:10Z","timestamp":1746171970000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2025.1592014\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":40,"alternative-id":["10.3389\/fnins.2025.1592014"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2025.1592014","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,2]]},"article-number":"1592014"}}